Dan Peisert is the Chief Executive Officer of Assertio, a commercial pharmaceutical company that focuses on offering differentiated products to patients.
Dan Peisert is the Chief Executive Officer of Assertio, a commercial pharmaceutical company that focuses on offering differentiated products to patients through a non-personal promotional model. Assertio's product portfolio includes Indocin, for the treatment of moderate to severe rheumatoid arthritis, and they acquired Spectrum Pharmaceuticals, Inc. in July 2023, which added the injection asset Rolvedon to their offerings.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide